AAAAAA

   
Results: 1-9 |
Results: 9
TYPE-A BEHAVIOR INTERVENTION IN PRIMARY HEALTH-CARE REDUCES HOSTILITYAND TIME PRESSURE - A STUDY IN SWEDEN
Authors: KARLBERG L KRAKAU I UNDEN AL
Citation: L. Karlberg et al., TYPE-A BEHAVIOR INTERVENTION IN PRIMARY HEALTH-CARE REDUCES HOSTILITYAND TIME PRESSURE - A STUDY IN SWEDEN, Social science & medicine, 46(3), 1998, pp. 397-402
LONG-TERM OUTCOME OF CONSERVATIVE THERAPY IN MEN PRESENTING WITH VOIDING SYMPTOMS AND PROSTATE-CANCER
Authors: STATTIN P BERGH A KARLBERG L TAVELIN B DAMBER JE
Citation: P. Stattin et al., LONG-TERM OUTCOME OF CONSERVATIVE THERAPY IN MEN PRESENTING WITH VOIDING SYMPTOMS AND PROSTATE-CANCER, European urology, 32(4), 1997, pp. 404-409
PSYCHOMETRIC PROPERTIES OF A BRIEF SELF-REPORT TYPE-A QUESTIONNAIRE FOR USE IN PRIMARY HEALTH-CARE
Authors: KARLBERG L KRAKAU I SJODEN PO UNDEN AL
Citation: L. Karlberg et al., PSYCHOMETRIC PROPERTIES OF A BRIEF SELF-REPORT TYPE-A QUESTIONNAIRE FOR USE IN PRIMARY HEALTH-CARE, Scandinavian journal of primary health care, 15(1), 1997, pp. 52-56
CELL-PROLIFERATION ASSESSED BY KI-67 IMMUNOREACTIVITY ON FORMALIN-FIXED TISSUES IS A PREDICTIVE FACTOR FOR SURVIVAL IN PROSTATE-CANCER
Authors: STATTIN P DAMBER JE KARLBERG L BERGH A
Citation: P. Stattin et al., CELL-PROLIFERATION ASSESSED BY KI-67 IMMUNOREACTIVITY ON FORMALIN-FIXED TISSUES IS A PREDICTIVE FACTOR FOR SURVIVAL IN PROSTATE-CANCER, The Journal of urology, 157(1), 1997, pp. 219-222
P53 IMMUNOREACTIVITY AS PROGNOSTIC MARKET FOR CANCER-SPECIFIC SURVIVAL IN PROSTATE-CANCER
Authors: STATTIN P BERGH A KARLBERG L NORDGREN H DAMBER JE
Citation: P. Stattin et al., P53 IMMUNOREACTIVITY AS PROGNOSTIC MARKET FOR CANCER-SPECIFIC SURVIVAL IN PROSTATE-CANCER, European urology, 30(1), 1996, pp. 65-72
BCL-2 IMMUNOREACTIVITY IN PROSTATE TUMORIGENESIS IN RELATION TO PROSTATIC INTRAEPITHELIAL NEOPLASIA, GRADE, HORMONAL STATUS, METASTATIC GROWTH AND SURVIVAL
Authors: STATTIN P DAMBER JE KARLBERG L NORDGREN H BERGH A
Citation: P. Stattin et al., BCL-2 IMMUNOREACTIVITY IN PROSTATE TUMORIGENESIS IN RELATION TO PROSTATIC INTRAEPITHELIAL NEOPLASIA, GRADE, HORMONAL STATUS, METASTATIC GROWTH AND SURVIVAL, Urological research, 24(5), 1996, pp. 257-264
LONG-TERM OUTCOME OF PATIENTS TREATED FOR HYDROCELE WITH THE SCLEROSANT AGENT SODIUM TETRADECYL SULFATE
Authors: STATTIN P KARLBERG L DAMBER JE
Citation: P. Stattin et al., LONG-TERM OUTCOME OF PATIENTS TREATED FOR HYDROCELE WITH THE SCLEROSANT AGENT SODIUM TETRADECYL SULFATE, Scandinavian journal of urology and nephrology, 30(2), 1996, pp. 109-113
5-YEAR FOLLOW-UP OF A PROSPECTIVE TRIAL OF RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY - NORDIC CYSTECTOMY TRIAL-I
Authors: MALMSTROM PU RINTALA E WAHLQVIST R HELLSTROM P HELLSTEN S HANNISDAL E ALFTHAN O RUSK J OPAS MA JAUHIAINEN K OTTELIN J PERMI J SALMELA H TAINIO H TALJA M TUHKANEN K VIITANEN J BREVIK B HOEG OM JOHANNESSEN NB FARSUND T MEDBY PC MURI O FOSSA SD OUS S SANDER S TVETER KJ OMLAND H STEINSVIK E URNES T WAALER G OGREID P OSTREM T ANDERSSON L EDSMYR F EKMAN P GUSTAFSON H NORMING U WIJKSTROM H KARLBERG L KIHL B LINDEBORG T
Citation: Pu. Malmstrom et al., 5-YEAR FOLLOW-UP OF A PROSPECTIVE TRIAL OF RADICAL CYSTECTOMY AND NEOADJUVANT CHEMOTHERAPY - NORDIC CYSTECTOMY TRIAL-I, The Journal of urology, 155(6), 1996, pp. 1903-1906
CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY
Authors: ANDERSEN JT EKMAN P WOLF H BEISLAND HO JOHANSSON JE KONTTURI M LEHTONEN T TVETER K BODKER A VEDEL O NORDLING J POULSEN AL SCHOU J HVIDT V HANSEN JB MEYHOFF HH ELDRUP J HARTWELL D COLSTRUP H LYNGDORF P NIELSEN AH LARSEN E WALTER S LARSEN EH THYBO E MOMMSEN S BROK KE PALM L GENSTER H ANDERSEN M KAUPPINEN P RAUVALA M HAKKINEN J TAMMELA T TAINIO H HYNNINEN O TIITINEN J LEHTORANTA K ALAOPAS M PERTTILA I PETAS A RINTALA E SALMINEN R JUUSELA H HANSSON E VONWENDT R TUHKANEN K TALJA M NURMI M PUNTALA P PERMI J PUOLAKKA VM VIITANEN J GISLASON T EINARSSON GV ERI LM KARLSEN S HOLME P SIVERTSEN SM STEINSVIK E SERVOLL E URNES T MALME PA JOHANSEN TEB OMLAND H NAGELHUS J KLOSTER SE SKJEGGESTAD O VADA K MORTENSEN R NYBERG G PETTERSSON G WEDMAN L BRATELL S FOLMERZ P ZACKRISSON B DAHLGREN K TILLEGARD A AUS G BERGDAHL S HUGOSSON J HOLMQUIST B EK A RADEMARK C KRISTIANSEN P HERMANSSON CG PEDERSEN K OSCARSSON C KIHL B OLSSON JO NELVIN L LEISSNER KH LUNDSTAM S HJERTBERG H VARENHORST E ANDERSSON SO WINDAHL T SWARTZ R AHLBERG B GEDDA S ANDERSTROM C EDDELAND S HANSSON R STROGERG P ADOLFSSON J BAUER P KLEIST H STORM B RANCH T STRAVSNES H BREKKAN E EKLUND T KARLBERG L MALICE MP BRONEE V WENNERLUND P ERIKSSON LO AASERUD E LEHMUSSAARI J SUOMIN R GABRIEL MA
Citation: Jt. Andersen et al., CAN FINASTERIDE REVERSE THE PROGRESS OF BENIGN PROSTATIC HYPERPLASIA - A 2-YEAR PLACEBO-CONTROLLED STUDY, Urology, 46(5), 1995, pp. 631-637
Risultati: 1-9 |